Lynne A. Bui - 11 Jan 2022 Form 3 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Director
Signature
/s/ Randy Milby as Attorney-In-Fact for Lynne Bui
Issuer symbol
THAR
Transactions as of
11 Jan 2022
Net transactions value
$0
Form type
3
Filing time
11 Jan 2022, 20:43:17 UTC
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HILS Options (right to purchase) 11 Jan 2022 Common stock 18,939 $13.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Registrant issued the Reporting Person the options on June 20, 2018. The options vest as follows: (i) 3,787 options vested on the date of grant and became exercisable on June 20, 2019 and (ii) the balance of the options shall vest and become exercisable in 48 equal monthly installments with the first installment vesting on July 20, 2019.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney